Page 33 - Loss Attributable News Today

Share this article Share this article *   A Supplemental Information section was added to the 2021 First Quarter Report in order to normalize key financial metrics due to the February 2021 Texas Events. *   The information contained within this press release is presented on a normalized basis. Unprecedented weather conditions in Texas negatively impacted financial results in the first quarter of 2021. Revenues Proportionate, on a normalized basis, up 1% to $166.5 million in Q1 2021 compa...

Article content Third quarter revenue of $32.0 million, up 3.8% from the previous quarter adjusting for removal of MedMen NY Inc. from continuing operations Total Retail Revenue increase of 8.2% quarter-over-quarter, inclusive of New York and Arizona stores Total Retail Adjusted EBITDA increased to $8.5 million from $6.0 million quarter-over-quarter, for a 22.5% margin, and Total Retail Adjusted EBITDA from continuing operations increased to $7.4 million from $5.5 million quarter-over-quarter f...

Jacobs Reports Fiscal Second Quarter Earnings Reports Strong Q2 Results and Raises Full-Year Fiscal 2021 Outlook ESG-Related Growth Opportunities Accelerating Across All Lines of Business Generated Over $1.1 Billion in Cash Flow from Operations Over Last Four Quarters PA Consulting Q2 Revenue Up 28% Year-Over-Year; Increasing FY21 Adj. EPS Expected Accretion Expects Robust FY22 Growth Driven by National Security Priorities and Global Infrastructure Modernization News provided by Share this arti...

Share this article Share this article ATLANTA, May 10, 2021 /PRNewswire/ -- Preferred Apartment Communities, Inc. (NYSE: APTS) ("we," "our," the "Company," "Preferred Apartment Communities" or "PAC") today reported results for the quarter ended March 31, 2021. Unless otherwise indicated, all per share results are reported based on the basic weighted average shares of Common Stock and Class A Units ("Class A Units") of the Preferred Apartment Communities Operating Partnership (our "Operating Par...

Share this article Share this article COLORADO SPRINGS, Colo., May 7, 2021 /PRNewswire/ -- Century Casinos, Inc. (Nasdaq Capital Market®: CNTY) today announced its financial results for the three months ended March 31, 2021. First Quarter 2021 Highlights* Net operating revenue was $72.4 million, a decrease of 17% from the three months ended March 31, 2020. Earnings from operations was $8.2 million, an increase of 126% from the three months ended March 31, 2020. Net loss attributable to Cent...

Reaffirms 2021 earnings guidance range of $3.00 - $3.30 per share ALLETE, Inc. (NYSE: ALE) today reported first quarter 2021 earnings of 99 cents per share on net income of $51.8 million. Last year’s results were $1.28 per share on net income of $66.3 million. The timing of income taxes and operating and maintenance expense in 2021 negatively impacted the quarter compared to internal expectations by approximately 15 cents per share, which are expected to reverse during the remainder of the ye...

Genesis Energy, L.P. (NYSE:GEL) today announced its first quarter results. We generated the following financial results for the first quarter of 2021: Net ...

Share this article Share this article HOUSTON, May 5, 2021 /PRNewswire/ -- Weatherford International plc (OTC Pink: WFTLF) ("Weatherford" or the "Company") announced today its results for the first quarter of 2021. Revenues for the first quarter of 2021 were $832 million, a decline of 1% sequentially and 32% year-on-year.  Reported operating loss was $13 million in the first quarter of 2021, compared to an operating loss of $107 million in the fourth quarter of 2020 and an operating loss of...

Evolent Health Announces First Quarter 2021 Results News provided by Share this article Share this article WASHINGTON, May 5, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended March 31, 2021. Highlights from the first quarter of 2021 announcement include: Quarter ended March 31, 2021: GAAP revenue of $215.1 million. Net loss att...

Synthetic Biologics Reports 2021 First Quarter Operational Highlights and Financial Results Initiated Phase 1b/2a Clinical Trial of SYN-004 in Allogeneic HCT Recipients for the Prevention of aGVHD Initiated Phase 1a Single-Ascending-Dose Clinical Trial of SYN-020 Intestinal Alkaline Phosphatase Reports $76.9 Million of Cash on Hand to Fund Clinical Programs Through Proof-of-Concept and Extend Operations into 2023 -- Conference Call Today at 4:30 p.m. (ET) -- News provided by Share this article ...